M&A Deal Summary

Exagen Acquires Cypress Bioscience - Diagnostic Business

On October 8, 2010, Exagen acquired life science company Cypress Bioscience - Diagnostic Business from Cypress Bioscience for 8M USD

Acquisition Highlights
  • This is Exagen’s 1st transaction in the Life Science sector.
  • This is Exagen’s largest (disclosed) transaction.
  • This is Exagen’s 1st transaction in the United States.
  • This is Exagen’s 1st transaction in California.

M&A Deal Summary
Date 2010-10-08
Target Cypress Bioscience - Diagnostic Business
Sector Life Science
Buyer(s) Exagen
Sellers(s) Cypress Bioscience
Deal Type Divestiture
Deal Value 8M USD

Target

Cypress Bioscience - Diagnostic Business

San Diego, California, United States
Cypress Bioscience - Diagnostic Business is a provider of diagnostic services.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Exagen

Vista, California, United States
Category Company
Founded 2002
Sector Life Science
Employees174
Revenue 53M USD (2023)
DESCRIPTION

Exagen is a patient-focused, discovery-driven, CLIA-certified, CAP-accredited laboratory focused on providing physicians with products that address the significant unmet need for accurate and timely diagnosis, prognosis and monitoring of ARD/CTD. Exagen was founded in 2002 and is based in Vista, California.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2010) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Cypress Bioscience

San Diego, California, United States
Category Company
Sector Life Science
DESCRIPTION

Cypress Bioscience, Inc. is committed to developing and commercializing pharmaceutical products and personalized medicine laboratory services that allow physicians to serve unmet medical needs.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2010) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-02-25 Proprius Pharmaceuticals

San Diego, California, United States

Proprius Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets personalized medicine solutions in rheumatology and autoimmune diseases.

Buy $38M
Mergr

Product

Company

Legal